Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human CCL3 Antibodies:
anti-Rat (Rattus) CCL3 Antibodies:
anti-Mouse (Murine) CCL3 Antibodies:
Go to our pre-filtered search.
Human Monoclonal CCL3 Primary Antibody for FACS - ABIN4897112
Shin, You, Kang, Lee, Yoo, Park, Kang, Kim, Mohanty, Shaw, Montgomery, Hwang, Kang: DNA Methylation Regulates the Differential Expression of CX3CR1 on Human IL-7Rαlow and IL-7Rαhigh Effector Memory CD8+ T Cells with Distinct Migratory Capacities to the Fractalkine. in Journal of immunology (Baltimore, Md. : 1950) 2015
Show all 2 Pubmed References
Mouse (Murine) Polyclonal CCL3 Primary Antibody for IP, WB - ABIN223561
Neff, Zgraggen, Neff, Jamnicki-Abegg, Suter, Schimmer, Booy, Joch, Pasch, Ward, Beck-Schimmer: Inflammatory response of tracheobronchial epithelial cells to endotoxin. in American journal of physiology. Lung cellular and molecular physiology 2005
Show all 2 Pubmed References
Human Polyclonal CCL3 Primary Antibody for IHC (p), WB - ABIN652466
Wang, Lin, Izumi, Jiang, Lai, Xu, Fang, Lu, Li, Xia, Chang: Increased infiltrated macrophages in benign prostatic hyperplasia (BPH): role of stromal androgen receptor in macrophage-induced prostate stromal cell proliferation. in The Journal of biological chemistry 2012
Show all 2 Pubmed References
Human Monoclonal CCL3 Primary Antibody for ELISA, WB - ABIN520044
Quek, Ho, Loprieno, Ellis, Elliott, Liu: A multiplex assay to measure RNA transcripts of prostate cancer in urine. in PLoS ONE 2012
Human Polyclonal CCL3 Primary Antibody for IHC, ELISA - ABIN1584813
Pajer, Nemes, Berzsenyi, Kovács, Pirity, Pajenda, Nógrádi, Dinnyés: Grafted murine induced pluripotent stem cells prevent death of injured rat motoneurons otherwise destined to die. in Experimental neurology 2015
Mouse (Murine) Monoclonal CCL3 Primary Antibody for FACS - ABIN4896814
Eberlein, Nguyen, Victorino, Golden-Mason, Rosen, Homann: Comprehensive assessment of chemokine expression profiles by flow cytometry. in The Journal of clinical investigation 2010
Human Monoclonal CCL3 Primary Antibody for FACS - ABIN4897111
Hutnick, Carnathan, Demers, Makedonas, Ertl, Betts: Adenovirus-specific human T cells are pervasive, polyfunctional, and cross-reactive. in Vaccine 2010
Human Monoclonal CCL3 Primary Antibody for CyTOF, FACS - ABIN4900054
Masih-Khan, Trudel, Heise, Li, Paterson, Nadeem, Wei, Roodman, Claudio, Bergsagel, Stewart: MIP-1alpha (CCL3) is a downstream target of FGFR3 and RAS-MAPK signaling in multiple myeloma. in Blood 2006
The CCL3 and CCL4 (show CCL4 Antibodies) chemokines might not be involved in differential susceptibility to the digestive and cardiac clinical forms of chronic Chagas disease, and it seems they do not influence the development of LVSD.
The serum levels of IL-8 (show IL8 Antibodies), MIP-1 alpha, MIP-1 beta (show CCL4 Antibodies), MMP-8 (show MMP8 Antibodies), Resistin (show RETN Antibodies), FLRG (show FSTL3 Antibodies), and BCAM (show BCAT2 Antibodies) were significantly higher in breast cancer patients, but LAP and TSH-beta (show TSHB Antibodies) levels were lower.
the DR3 (show TNFRSF25 Antibodies)/TL1A (show TNFSF15 Antibodies) pathway directly enhances human OC formation and resorptive activity, controlling expression and activation of CCL3 and MMP-9 (show MMP9 Antibodies).
serum levels of MIP-1alpha could predict survival outcomes in patients with ENKTL.
elevated CCL3 in the leukemic environment suppresses er (show CCL1 Antibodies)ythropoiesis via CCR1-p38 activation
analysis of sudden infant death syndrome brains shows downregulation of MyD88 (show MYD88 Antibodies) in tissue from SIDS (show IDS Antibodies) brains, as well as the downregulation of the genes encoding CCL3 and UNC13 (show UNC13B Antibodies) in the liver
we demonstrate an association of CCL3 expression by CLL cells with increased numbers of CD3 (show CD3 Antibodies)+ T cells and CD57 (show B3GAT1 Antibodies)+ cells in the lymph node microenvironment, which may promote CLL cell survival and proliferation.
The N termini of CC chemokines are shown to be involved in receptor binding and oligomerization. We also report an alternative CCL3 oligomer structure that reveals how conformational changes in CCL3 N termini profoundly alter its surface properties and dimer-dimer interactions to affect GAG binding and oligomerization. Such complexity in oligomerization and GAG binding enables intricate, physiologically relevant regulatio
CCL3 promotes VEGF-A (show VEGFA Antibodies) expression and angiogenesis in human osteosarcoma cells by down-regulating miR (show MLXIP Antibodies)-374b expression via JNK (show MAPK8 Antibodies), ERK (show EPHB2 Antibodies), and p38 (show CRK Antibodies) signaling pathways.
The residues on the N-loop and beta-sheets of MIP-1a are close to both CCR1 and CCR5, and those in the C-terminal helix region are close to CCR5.
CCL3 plays a significant role in the clearance of infection and resolution of otitis media inflammation and contributes to mucosal host defense of the nasopharyngeal niche, a reservoir for middle ear and upper respiratory infections.
Cytokine array analysis demonstrated that the chemokine (show CCL1 Antibodies) CCL3 was elevated in the plasma of AML (show RUNX1 Antibodies) mice and patients. CCL3 inhibited erythroid differentiation of hematopoietic stem cells, common myeloid progenitors and especially megakaryocytic-erythroid progenitors.
MCP (show CR1L Antibodies) chemokines are activated in peripheral tissues of breast cancer-bearing mice, by a mechanism that involves breast cancer cell-derived Ccl3.
These observations suggest that intra-BM basophil expansion can favor leukemia-tropic hematopoiesis in myeloid leukemia (show BCL11A Antibodies) by providing CCL3, a potent inhibitor of normal hematopoiesis and that basophil-derived CCL3 may be a novel target molecule for the treatment of myeloid leukemia (show BCL11A Antibodies).
A marked increase of CCL3 mRNA expression was observed in inflamed paws, with CCL3 protein detected in neutrophils and macrophages by immunohistochemical experiments.
CCL2 (show CCL2 Antibodies)/CCL3 double-mutant animals are viable, fertile, and do not present with gross abnormalities. Cuprizone increased CCL3 expression in wild-type but not mutant mice. Cuprizone-induced demyelination, oligodendrocyte loss, and astrogliosis were significantly ameliorated in the cortex but not corpus callosum of chemokine (show CCL1 Antibodies)-deficient animals.
these data suggest that the chemokine (show CCL1 Antibodies) CCL3 is an hippocampal neuromodulator able to regulate synaptic plasticity mechanisms involved in learning and memory functions.
Ccl3 mRNAs increased within 5 h after injury in mouse cortical slices.
Previous exposure to noninjurious ventilation induces a state of tolerance to ventilator-induced lung injury. Down regulation of the chemokine (show CCL1 Antibodies) gene Ccl3 could be the mechanism responsible for this effect.
the tissue fibrinolytic system contributes to the induction of macrophage recruitment and CCL3 at the bone injury site, thereby, leading to the enhancement of the repair process.
variation in the CCL18 (show CCL18 Antibodies)-CCL3-CCL4 (show CCL4 Antibodies) chemokine (show CCL1 Antibodies) gene cluster influences HIV Type 1 transmission and AIDS disease progression
CCL3, CCL4 (show CCL4 Antibodies) and CCL5 (show CCL5 Antibodies) gene expression was evaluated in response to simian-human immunodeficiency virus (SHIV) infection in a rhesus macaque model.
Stress decreased MIP-1alpha gene expression in both CeA (show CEACAM3 Antibodies) lesioned and non-lesioned animals. But, the CeA (show CEACAM3 Antibodies) lesions increased the tissue expression of MIP-1alpha mRNA prior to and after stress exposure.
This locus represents a small inducible cytokine. The encoded protein, also known as macrophage inflammatory protein 1 alpha, plays a role in inflammatory responses through binding to the receptors CCR1, CCR4 and CCR5. Polymorphisms at this locus may be associated with both resistance and susceptibility to infection by human immunodeficiency virus type 1.
C-C motif chemokine 3
, macrophage inflammatory protein 1 alpha
, G0/G1 switch regulatory protein 19-1
, PAT 464.1
, macrophage inflammatory protein 1-alpha
, small inducible cytokine A3 (homologous to mouse Mip-1a)
, tonsillar lymphocyte LD78 alpha protein
, Macrophage inflammatory protein 1 alpha (Small inducible cytokine A3)
, small inducible cytokine A3
, small-inducible cytokine A3
, MIP-1 alpha
, MIP1 (a)
, heparin-binding chemotaxis protein
, macrophage inflammatory protein-1alpha
, chemokine (C-C motif) ligand 3-like 1
, CC chemokine ligand 3
, chemokine (C-C motif) ligand 3-like 3
, CCL3-like 1